Companion deal raises CM evidence issues
THE Pharmacy Guild says its deal to promote Blackmores complementary medicines (CMs) has been withdrawn in view of “media reporting of the endorsement which was ill-informed and inflammatory”.
My own view is that the deal itself was ill-informed and inflammatory. It involved an undisclosed payment by Blackmores to enable GuildCare dispensing software to prompt pharmacists entering prescriptions to on-sell Blackmores “Companion” products.
The four Guild-endorsed Blackmores products were a probiotic to be promoted with antibiotics, zinc with blood pressure drugs, coenzyme Q10 with vitamin D3 for statins and magnesium with proton pump inhibitors.
The National Prescribing Service (NPS) and others have pointed out that there is no good evidence to support the routine use of these supplements with the prescription drugs targeted.
In addition, this practice would unnecessarily add to the “medication burden”